Meyka Pro banner
State Street SPDR S&P 400 Mid Cap Value ETF

Stay Updated with the Latest State Street SPDR S&P 400 Mid Cap Value ETF MDYV News in Real Time

Find MDYV news now at Meyka AI. Stay informed with the latest State Street SPDR S&P 400 Mid Cap Value ETF stocks updates, including price news, market analysis, and expert insights.

MDYVAMEX
Financial ServicesAsset Management - Global
$95.19
$0.52(0.54%)
U.S. Market opens in 17h 13m
Father Pushes ‘Lily’s Law’ After Teen Hiker Dies in NSW Bushland
📅 in about 3 hours

Father Pushes ‘Lily’s Law’ After Teen Hiker Dies in NSW Bushland

After 18-year-old Lily Hooper’s death in NSW bushland, her father pushes for ‘Lily’s Law’ to require GPS trackers and safety beacons for hikers. NSW Premier Chris Minns pledges to honour her memory.

Read more 12
Tamil Nadu CM Vijay Drops Parandur Airport, Announces ₹4,000 Crore LPG Scheme on August 24
📅 in about 2 hours

Tamil Nadu CM Vijay Drops Parandur Airport, Announces ₹4,000 Crore LPG Scheme on August 24

CM Vijay scraps Parandur airport, launches ₹4,000 crore free LPG cylinder scheme for 1.34 crore families starting Pongal 2027, and expands free bus travel for women and transgender persons from October 2.

Read more 12
Australia Post Hires 3,500 Seasonal Workers; Truck Drivers Earn Up to $42.26/Hour
📅 in 5 minutes

Australia Post Hires 3,500 Seasonal Workers; Truck Drivers Earn Up to $42.26/Hour

Australia Post opens 3,500 seasonal jobs for Christmas rush. Truck drivers earn $42.26/hour, parcel sorters $35.83/hour. Applications open now; roles start September and October.

Read more 12
Hindustan Zinc (NSE: HINDZINC) Advances 2.5% to ₹609.60, Extends Rally to Third Straight Session
📅 3 hours ago

Hindustan Zinc (NSE: HINDZINC) Advances 2.5% to ₹609.60, Extends Rally to Third Straight Session

Hindustan Zinc shares rose 2.47% to ₹609.60 on Monday, August 24, 2026. The stock extended its rally to a third consecutive session, outperforming the broader market. Hindustan Zinc is up 40.23% over the past year, against a 3.13% drop in the Nifty 50. Silver Strength Keeps Driving the Rally Hindustan Zinc’s Q1 FY27 results, released…

Read more 12
XRP vs RLUSD: Can Ripple’s Banking Expansion Drive Long-Term Token Demand?
📅 4 hours ago

XRP vs RLUSD: Can Ripple’s Banking Expansion Drive Long-Term Token Demand?

XRP trades near $1.57 in late August 2026, after rallying from $1.00 in under two weeks. The move sits alongside rapid growth in RLUSD, Ripple’s own stablecoin. Investors now ask whether Ripple’s banking expansion actually pulls demand toward XRP, or toward RLUSD instead. XRP’s August Rally, By the Numbers XRP climbed from $1.00 to above…

Read more 12
Sony Faces PlayStation Blackout as Gamers Protest Disc Phase-Out by 2028
📅 4 hours ago

Sony Faces PlayStation Blackout as Gamers Protest Disc Phase-Out by 2028

PlayStation gamers boycott Sony through August 30 over plans to end physical disc production in 2028. Sony’s licensing emails spark debate on digital ownership rights.

Read more 12
Shein Targets $27B (£20B) Valuation in Long-Awaited Hong Kong IPO, Raising to $1.8B
📅 5 hours ago

Shein Targets $27B (£20B) Valuation in Long-Awaited Hong Kong IPO, Raising to $1.8B

Shein launched its Hong Kong IPO on Monday, August 24, 2026, targeting a valuation of up to 27billion.Thefast-fashionretaileraimstoraiseasmuchasHK13.86 billion, or 1.77billion.ShareswillpricebetweenHK47.60 and HK$49.50 apiece.  IPO Structure and Timeline Shein is selling 280 million Class B shares in the offering. The company will confirm its final IPO price on August 31, 2026. Trading on the Hong…

Read more 12
Australia’s Big Banks Hike Credit Card Fees Before October 1 Surcharge Ban
📅 5 hours ago

Australia’s Big Banks Hike Credit Card Fees Before October 1 Surcharge Ban

Commonwealth Bank, Westpac, and NAB are raising credit card fees and cutting rewards as Australia’s surcharge ban looms on October 1, 2026. Banks aim to offset A$600 million in lost revenue.

Read more 12
Hanmi Pharm (KRX: 128940) Hits 30% Daily Limit on $2.3B Obesity Drug Licensing Deal with Genentech  
📅 5 hours ago

Hanmi Pharm (KRX: 128940) Hits 30% Daily Limit on $2.3B Obesity Drug Licensing Deal with Genentech  

Hanmi Pharm shares surged 30% on August 24, 2026, hitting the daily price limit after the South Korean drugmaker announced a licensing deal with Genentech worth up to $2.3 billion. The agreement covers HM17321, an experimental obesity treatment designed to reduce body fat while preserving muscle mass. Hanmi will receive $190 million upfront, while Genentech…

Read more 12

MDYV News FAQ